Nonoperating Income (Expense) in USD of Baudax Bio, Inc. from Q3 2018 to Q3 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Baudax Bio, Inc. quarterly/annual Nonoperating Income (Expense) history and change rate from Q3 2018 to Q3 2023.
- Baudax Bio, Inc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2023 was -$115K, a 77.5% increase year-over-year.
- Baudax Bio, Inc. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2023 was -$3.72M, a 68.5% decline year-over-year.
- Baudax Bio, Inc. annual Nonoperating Income (Expense) for 2022 was -$2.3M, a 211% decline from 2021.
- Baudax Bio, Inc. annual Nonoperating Income (Expense) for 2021 was -$738K, a 1740% decline from 2020.
- Baudax Bio, Inc. annual Nonoperating Income (Expense) for 2020 was $45K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)